# Physiologic Study of Cerebral Perfusion

> **NCT02744625** · PHASE4 · COMPLETED · sponsor: **Centre de recherche du Centre hospitalier universitaire de Sherbrooke** · enrollment: 22 (actual)

## Conditions studied

- Cerebral Perfusion Pressure
- Vasopressor Agents
- Shock
- Magnetic Resonance Imaging (MRI), Functional

## Interventions

- **DRUG:** Higher doses of vasopressor therapy for a MAP of 75 mmHg
- **DRUG:** Lower doses of vasopressor therapy for a MAP of 65 mmHg
- **DRUG:** Propofol for light sedation

## Key facts

- **NCT ID:** NCT02744625
- **Lead sponsor:** Centre de recherche du Centre hospitalier universitaire de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02744625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02744625, "Physiologic Study of Cerebral Perfusion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02744625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*